11 – 20 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
(
- Contribution to journal › Scientific review
-
Mark
Molecular pathology of the non-luminal Ba/Sq-like and Sc/NE-like classes of urothelial tumours : An integrated immunohistochemical analysis
(
- Contribution to journal › Article
-
Mark
Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing : A Systematic Review
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Tumor Subtyping : Making Sense of Heterogeneity with a Goal Toward Treatment
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
(
- Contribution to journal › Article
- 2019
-
Mark
Molecular subtypes applied to a population-based modern cystectomy series do not predict cancer-specific survival
(
- Contribution to journal › Article
-
Mark
Intravesical therapy - BCG and beyond
(
- Contribution to journal › Article
-
Mark
Molecular pathology of the luminal class of urothelial tumors
(
- Contribution to journal › Article
- 2018
-
Mark
Molecular subtype classification of urothelial carcinoma in Lynch syndrome
(
- Contribution to journal › Article
-
Mark
Molecular subtype profiling of urothelial carcinoma using a subtype-specific immunohistochemistry panel
(
- Chapter in Book/Report/Conference proceeding › Book chapter